Merit Financial Group, LLC Ardelyx, Inc. Transaction History
Merit Financial Group, LLC
- $8.37 Billion
- Q2 2025
A detailed history of Merit Financial Group, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 21,143 shares of ARDX stock, worth $118,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,143
Previous 15,306
38.14%
Holding current value
$118,400
Previous $75,000
9.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
227Shares Held
170MCall Options Held
611KPut Options Held
2.3M-
Black Rock Inc. New York, NY17.6MShares$98.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$89.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$84.3 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$65.3 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$64.2 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...